Dihydroergotamine nasal and Insulin Glulisine (Vials)
Determining the interaction of Dihydroergotamine nasal and Insulin Glulisine (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine nasal-Insulin glulisine Subcutaneous
- Dihydroergotamine nasal-Insulin human inhaled Inhalation
- Dihydroergotamine nasal-Insulin human regular Injection
- Dihydroergotamine nasal-Insulin inhalation
- Dihydroergotamine nasal-Insulin isophane
- Dihydroergotamine nasal-Insulin isophane and insulin regular
- Insulin Glulisine (Vials)-Dihydroergotamine Nasal Spray
- Insulin Glulisine (Vials)-Dilacor XR
- Insulin Glulisine (Vials)-Dilantin
- Insulin Glulisine (Vials)-Dilantin Infatabs
- Insulin Glulisine (Vials)-Dilantin injection
- Insulin Glulisine (Vials)-Dilantin Kapseals